Malignant Melanoma: Advances in Treatment

Smith, Vanessa; Walton, Shernaz

Journal of the Dermatology Nurses' Association:
doi: 10.1097/JDN.0000000000000044
Feature Articles
Abstract

ABSTRACT: We discuss the recent breakthroughs in the treatment of metastatic malignant melanoma. New therapies, which target the mitogen-activated protein kinase pathway, such as BRAF inhibitors and MEK inhibitors, may provide hope for those with metastatic disease where, historically, treatment has not been successful.

Author Information

Vanessa Smith, MRCP, Dermatology Department, Hull Royal Infirmary, Hull York Medical School, Hull, East Yorkshire.

Shernaz Walton, MD, FRCP (Lon), Dermatology Department, Hull Royal Infirmary, Hull York Medical School, Hull, East Yorkshire.

The authors declare no conflict of interest.

Correspondence concerning this article should be addressed to Shernaz Walton, MD, FRCP (Lon), Hull and East Yorkshire Hospitals, NHS Trust, Anlaby Road, Hull HU3 2JZ, East Yorkshire, United Kingdom. E-mail: shernaz.walton@hey.nhs.uk

Copyright © 2014 by the Dermatology Nurses' Association.